
The Future of Pharmaceutical Inspections
At the recently held ISPE Singapore Affiliate Conference & Exhibition 2022, Dr Joey Gouws, the Team Lead of Inspections of the World Health Organization Prequalification
At the recently held ISPE Singapore Affiliate Conference & Exhibition 2022, Dr Joey Gouws, the Team Lead of Inspections of the World Health Organization Prequalification
How much do you know about WHO and the role it plays in providing access to medicines and health products? As shared by Dr Joey
Often on projects in the pharmaceutical industry, we are asked various questions regarding cross-contamination prevention. It could be a greenfield project for a multi-products and
Suspension of a site’s GMP certification imposes substantial stress and impact on business, as well as the potential shortage of market supply. This case study
Pharmaceutical quality is quintessential. Any departures from pharmaceutical quality are called deviations and can occur at any point during a process or product lifecycle. Deviations
Raise your hand if you have mixed feelings about inspections, regardless of whether they’re internal audits, the ones from your client/MAH or, perhaps the scariest,
Article 7.4 of EU Directive 2003/94, which lays down the principles and guidelines of GMP, requires that: ‘The personnel shall receive initial and ongoing training,
Key learnings from NSF International’s training program The Deviation and Corrective and Preventive Action (CAPA) Management training by NSF has further developed my understanding of
In the pharmaceutical industry, quality is one of the foremost considerations. Technological evolution has enabled new ways of delivering quality, which go beyond compliance. In
I might be saying it too often: the pharmaceutical industry is highly regulated. But what regulates our practices? It could be federal codes, regulations, directives
Vision Exchange, 2 Venture Drive #13-27 Singapore 608526